To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Precision Medical Group, backed by Berkshire Partners, TPG Growth, awaits first round bids
Berkshire, which co-led a $275 million investment in Precision in late 2017 alongside TPG Growth, intends to remain invested in the provider of clinical trial and drug commercialization services.
